FDA Investigator: Alifiya H. Ghadiali
- Alifiya H. Ghadiali first started conducting FDA inspections in 2022, with the last inspection in 2024. Over that time, Alifiya H. Ghadiali has conducted 6 inspections at 6 companies across 6 sites.
Get Alifiya Ghadiali's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Lentigen Technology Inc, Gaithersburg | 2024
Out-of-stock
Alifiya H. Ghadiali
Biologics Form 483
FDA 483 Humacyte Global Inc, Durham | 2024
Out-of-stock
Alifiya H. Ghadiali
Biologics Form 483
FDA 483 Biogen U.S. Corporation, Research Triangle Park | 2022
Out-of-stock
Alifiya H. Ghadiali
Biologics Form 483
FDA 483 Uniqure Inc, Lexington | 2022
Out-of-stock
Alifiya H. Ghadiali
Biologics Form 483
Co-Investigators (17)
- Zainab Y. Mansaray-Storms, FDA Investigator
- Christine Harman, FDA Investigator
- Sharmila Shrestha, FDA Investigator
- Alan G. Baer,
- Laura K. Demaster,
- Y N. Nguyen,
- Laura M. Ricles, FDA Investigator
- Jin S. Hong,
- Xiuju Lu, FDA Investigator
- Andrew E. Timmons,
- Prajakta A. Varadkar, FDA Investigator
- Gregory A. Price, FDA Investigator
- Daniel Lagasse, FDA Investigator
- Unnee Ranjan, FDA Investigator
- Christian Lynch, FDA Investigator
- Anurag Sharma, FDA Investigator
- Emmanuel Adu-Gyamfi, FDA Investigator